These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34324117)

  • 1. The Impact of the ISCHEMIA Trial on Clinical Practice: an Interventionist's Perspective.
    Mavromatis K; Gershlick A
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1019-1026. PubMed ID: 34324117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
    White HD; O'Brien SM; Alexander KP; Boden WE; Bangalore S; Li J; Manjunath CN; Lopez-Sendon JL; Peteiro J; Gosselin G; Berger JS; Maggioni AP; Reynolds HR; Hochman JS; Maron DJ
    JAMA Cardiol; 2021 Sep; 6(9):1023-1031. PubMed ID: 33938917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Invasive or Conservative Strategy for Stable Coronary Disease.
    Maron DJ; Hochman JS; Reynolds HR; Bangalore S; O'Brien SM; Boden WE; Chaitman BR; Senior R; López-Sendón J; Alexander KP; Lopes RD; Shaw LJ; Berger JS; Newman JD; Sidhu MS; Goodman SG; Ruzyllo W; Gosselin G; Maggioni AP; White HD; Bhargava B; Min JK; Mancini GBJ; Berman DS; Picard MH; Kwong RY; Ali ZA; Mark DB; Spertus JA; Krishnan MN; Elghamaz A; Moorthy N; Hueb WA; Demkow M; Mavromatis K; Bockeria O; Peteiro J; Miller TD; Szwed H; Doerr R; Keltai M; Selvanayagam JB; Steg PG; Held C; Kohsaka S; Mavromichalis S; Kirby R; Jeffries NO; Harrell FE; Rockhold FW; Broderick S; Ferguson TB; Williams DO; Harrington RA; Stone GW; Rosenberg Y;
    N Engl J Med; 2020 Apr; 382(15):1395-1407. PubMed ID: 32227755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease.
    Boden WE; Stone PH
    Annu Rev Med; 2023 Jan; 74():189-198. PubMed ID: 36318679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.
    Nguyen DD; Spertus JA; Alexander KP; Newman JD; Dodson JA; Jones PG; Stevens SR; O'Brien SM; Gamma R; Perna GP; Garg P; Vitola JV; Chow BJW; Vertes A; White HD; Smanio PEP; Senior R; Held C; Li J; Boden WE; Mark DB; Reynolds HR; Bangalore S; Chan PS; Stone GW; Arnold SV; Maron DJ; Hochman JS;
    J Am Coll Cardiol; 2023 May; 81(17):1697-1709. PubMed ID: 37100486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
    Spertus JA; Jones PG; Maron DJ; O'Brien SM; Reynolds HR; Rosenberg Y; Stone GW; Harrell FE; Boden WE; Weintraub WS; Baloch K; Mavromatis K; Diaz A; Gosselin G; Newman JD; Mavromichalis S; Alexander KP; Cohen DJ; Bangalore S; Hochman JS; Mark DB;
    N Engl J Med; 2020 Apr; 382(15):1408-1419. PubMed ID: 32227753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ISCHEMIA in stable ischemic heart disease.
    Spilias N; Zorach B; Denby K; Ellis S
    Cleve Clin J Med; 2020 Jun; 87(7):401-409. PubMed ID: 32636193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.
    Songco AV; Brener SJ
    Curr Cardiol Rep; 2012 Aug; 14(4):397-407. PubMed ID: 22555943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
    Reynolds HR; Cyr DD; Merz CNB; Shaw LJ; Chaitman BR; Boden WE; Alexander KP; Rosenberg YD; Bangalore S; Stone GW; Held C; Spertus J; Goetschalckx K; Bockeria O; Newman JD; Berger JS; Elghamaz A; Lopes RD; Min JK; Berman DS; Picard MH; Kwong RY; Harrington RA; Thomas B; O'Brien SM; Maron DJ; Hochman JS;
    J Am Heart Assoc; 2024 Mar; 13(5):e029850. PubMed ID: 38410945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Therapy Versus Revascularization in Patients with Stable Ischemic Heart Disease and Advanced Chronic Kidney Disease.
    Paul TK; Mamas MA; Shanmugasundaram M; Nagarajarao HS; Ojha CP; Jneid H; Kumar G; White CJ
    Curr Cardiol Rep; 2021 Mar; 23(4):23. PubMed ID: 33655382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.